Abbott Enterprise Value Over E B I T D A from 2010 to 2024
| ABT Stock | USD 114.22 2.32 1.99% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 18.94178555 | Current Value 19.89 | Quarterly Volatility 6.89981573 |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 605.1 M or Selling General Administrative of 6.2 B, as well as many indicators such as Price To Sales Ratio of 5.01, Dividend Yield of 0.0176 or PTB Ratio of 2.62. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Enterprise Value Over E B I T D A |
Latest Abbott Laboratories' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Abbott Laboratories over the last few years. It is Abbott Laboratories' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Abbott Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 18.88 | |
| Geometric Mean | 17.05 | |
| Coefficient Of Variation | 36.54 | |
| Mean Deviation | 5.02 | |
| Median | 19.89 | |
| Standard Deviation | 6.90 | |
| Sample Variance | 47.61 | |
| Range | 22.8365 | |
| R-Value | 0.65 | |
| Mean Square Error | 29.52 | |
| R-Squared | 0.42 | |
| Significance | 0.01 | |
| Slope | 1.00 | |
| Total Sum of Squares | 666.50 |
Abbott Enterprise Value Over E B I T D A History
About Abbott Laboratories Financial Statements
Abbott Laboratories shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 18.94 | 19.89 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.